BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22493441)

  • 1. Mechanism of β-catenin-mediated transcriptional regulation of epidermal growth factor receptor expression in glycogen synthase kinase 3 β-inactivated prostate cancer cells.
    Guturi KK; Mandal T; Chatterjee A; Sarkar M; Bhattacharya S; Chatterjee U; Ghosh MK
    J Biol Chem; 2012 May; 287(22):18287-96. PubMed ID: 22493441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor regulates beta-catenin location, stability, and transcriptional activity in oral cancer.
    Lee CH; Hung HW; Hung PH; Shieh YS
    Mol Cancer; 2010 Mar; 9():64. PubMed ID: 20302655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proline oxidase, a p53-induced gene, targets COX-2/PGE2 signaling to induce apoptosis and inhibit tumor growth in colorectal cancers.
    Liu Y; Borchert GL; Surazynski A; Phang JM
    Oncogene; 2008 Dec; 27(53):6729-37. PubMed ID: 18794809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of beta-catenin signalling increases StarD7 gene expression in JEG-3 cells.
    Rena V; Angeletti S; Panzetta-Dutari G; Genti-Raimondi S
    Placenta; 2009 Oct; 30(10):876-83. PubMed ID: 19679347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate activation of androgen receptor by relaxin via beta-catenin pathway.
    Liu S; Vinall RL; Tepper C; Shi XB; Xue LR; Ma AH; Wang LY; Fitzgerald LD; Wu Z; Gandour-Edwards R; deVere White RW; Kung HJ
    Oncogene; 2008 Jan; 27(4):499-505. PubMed ID: 17653089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Wnt/β-catenin signaling mediates ursolic acid-induced apoptosis in PC-3 prostate cancer cells.
    Park JH; Kwon HY; Sohn EJ; Kim KA; Kim B; Jeong SJ; Song JH; Koo JS; Kim SH
    Pharmacol Rep; 2013; 65(5):1366-74. PubMed ID: 24399733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Embelin-Induced Apoptosis of Human Prostate Cancer Cells Is Mediated through Modulation of Akt and β-Catenin Signaling.
    Park N; Baek HS; Chun YJ
    PLoS One; 2015; 10(8):e0134760. PubMed ID: 26252009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cadherin switching and activation of beta-catenin signaling underlie proinvasive actions of calcitonin-calcitonin receptor axis in prostate cancer.
    Shah GV; Muralidharan A; Gokulgandhi M; Soan K; Thomas S
    J Biol Chem; 2009 Jan; 284(2):1018-30. PubMed ID: 19001380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system.
    Latasa MU; Salis F; Urtasun R; Garcia-Irigoyen O; Elizalde M; Uriarte I; Santamaria M; Feo F; Pascale RM; Prieto J; Berasain C; Avila MA
    PLoS One; 2012; 7(12):e52711. PubMed ID: 23285165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells.
    Li Y; Wang Z; Kong D; Murthy S; Dou QP; Sheng S; Reddy GP; Sarkar FH
    J Biol Chem; 2007 Jul; 282(29):21542-50. PubMed ID: 17522055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
    Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
    Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways.
    Yan D; Avtanski D; Saxena NK; Sharma D
    J Biol Chem; 2012 Mar; 287(11):8598-612. PubMed ID: 22270359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of a role for activation of Wnt/beta-catenin signaling in the resistance of plasma cells to lenalidomide.
    Bjorklund CC; Ma W; Wang ZQ; Davis RE; Kuhn DJ; Kornblau SM; Wang M; Shah JJ; Orlowski RZ
    J Biol Chem; 2011 Apr; 286(13):11009-20. PubMed ID: 21189262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p68/DdX5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancer.
    Clark EL; Hadjimichael C; Temperley R; Barnard A; Fuller-Pace FV; Robson CN
    PLoS One; 2013; 8(1):e54150. PubMed ID: 23349811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
    Chen Q; Zheng PS; Yang WT
    Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNAJB6 chaperones PP2A mediated dephosphorylation of GSK3β to downregulate β-catenin transcription target, osteopontin.
    Mitra A; Menezes ME; Pannell LK; Mulekar MS; Honkanen RE; Shevde LA; Samant RS
    Oncogene; 2012 Oct; 31(41):4472-83. PubMed ID: 22266849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer.
    Tsuchiya K; Nakamura T; Okamoto R; Kanai T; Watanabe M
    Gastroenterology; 2007 Jan; 132(1):208-20. PubMed ID: 17241872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective.
    Gao X; Cai Y; Wang Z; He W; Cao S; Xu R; Chen H
    J Transl Med; 2019 Sep; 17(1):308. PubMed ID: 31511014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
    Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
    Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Catenin nuclear localization positively feeds back on EGF/EGFR-attenuated AJAP1 expression in breast cancer.
    Xu C; Liu F; Xiang G; Cao L; Wang S; Liu J; Meng Q; Xu D; Lv S; Jiao J; Niu Y
    J Exp Clin Cancer Res; 2019 Jun; 38(1):238. PubMed ID: 31171012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.